Branched‐Chain Amino Acids in Computed Tomography–Defined Adipose Depots and Coronary Artery Disease: A PROMISE Trial Biomarker Substudy
Authors:
- Elizabeth ZhaoEZElizabeth Zhao
- Stephanie N. GiamberardinoSGStephanie N. Giamberardino
- Neha J. PagidipatiNPNeha J. Pagidipati
- Deepak VooraDeepak Voora
- Geoffrey S. GinsburgGGGeoffrey S. Ginsburg
- Udo HoffmannUHUdo Hoffmann
- Júlia KarádyJKJúlia Karády
- Maros FerencikMFMaros Ferencik
- Pamela S. DouglasPDPamela S. Douglas
- Borek FoldynaBFBorek Foldyna
- Svati H. ShahSSSvati H. Shah
Open Access
- 6 June 2023
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 12 (11) , e028410
Abstract
Background: The interplay between branched‐chain amino acid (BCAA) metabolism, an important pathway in adiposity and cardiometabolic disease, and visceral adipose depots such as hepatic steatosis (HS) and epicardial adipose tissue is unknown. We leveraged the PROMISE clinical trial with centrally adjudicated coronary computed tomography angiography imaging to determine relationships between adipose depots, BCAA dysregulation, and coronary artery disease (CAD). Methods and Results: The PROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) trial randomized 10 003 outpatients with stable chest pain to computed tomography angiography versus standard‐of‐care diagnostics. For this study, we included 1798 participants with available computed tomography angiography data and biospecimens. Linear and logistic regression were used to determine associations between a molar sum of BCAAs measured by nuclear magnetic resonance spectroscopy with body mass index, adipose traits, and obstructive CAD. Mendelian randomization was then used to determine if BCAAs are in the causal pathway for adipose depots or CAD. The study sample had a mean age of 60 years (SD, 8.0), body mass index of 30.6 (SD, 5.9), and epicardial adipose tissue volume of 57.3 (SD, 21.3) cm 3 /m 2 ; 27% had HS, and 14% had obstructive CAD. BCAAs were associated with body mass index (multivariable beta 0.12 per SD increase in BCAA [95% CI, 0.08–0.17]; P =4×10 −8 ). BCAAs were also associated with HS (multivariable odds ratio [OR], 1.46 per SD increase in BCAAs [95% CI, 1.28–1.67]; P =2×10 −8 ), but BCAAs were associated only with epicardial adipose tissue volume (odds ratio, 1.18 [95% CI, 1.07–1.32]; P =0.002) and obstructive CAD (OR, 1.18 [95% CI, 1.04–1.34]; P =0.009) in univariable models. Two‐sample Mendelian randomization did not support the role of BCAAs as within the causal pathways for HS or CAD. Conclusions: BCAAs have been implicated in the pathogenesis of cardiometabolic diseases, and adipose depots have been associated with the risk of CAD. Leveraging a large clinical trial, we further establish the role of dysregulated BCAA catabolism in HS and CAD, although BCAAs did not appear to be in the causal pathway of either disease. This suggests that BCAAs may serve as an independent circulating biomarker of HS and CAD but that their association with these cardiometabolic diseases is mediated through other pathways.Keywords
This publication has 38 references indexed in Scilit:
- Hepatic steatosis and cardiovascular disease outcomes: An analysis of the Framingham Heart StudyJournal of Hepatology, 2015
- Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver diseaseAmino Acids, 2014
- NMR measurement of LDL particle number using the Vantera® Clinical AnalyzerClinical Biochemistry, 2014
- PROspective Multicenter Imaging Study for Evaluation of chest pain: Rationale and design of the PROMISE trialAmerican Heart Journal, 2014
- Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterizationAtherosclerosis, 2014
- Branched chain amino acids are novel biomarkers for discrimination of metabolic wellnessMetabolism, 2013
- Plasma metabolomic profile in nonalcoholic fatty liver diseaseMetabolism, 2011
- A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin ResistanceCell Metabolism, 2009
- Lipoprotein Particle Analysis by Nuclear Magnetic Resonance SpectroscopyClinics In Laboratory Medicine, 2006
- Effects of brief starvation on muscle amino acid metabolism in nonobese man.Journal of Clinical Investigation, 1976